It is also worth exploring the possibility of IFNβ1 agonists as anti-melanoma agents as small molecules eliciting the type 1 interferon response have been investigated as candidate anti-viral agents [41] and may have application to melanoma therapy. Here, IFNB1 is linked to melanoma.